Finasteride/Minoxidil/Tretinoin Foam

Finasteride/Minoxidil/Tretinoin Foam is a compounded topical hair loss treatment designed to address androgenetic alopecia (pattern hair loss) by combining three active agents with complementary mechanisms: finasteride, minoxidil, and tretinoin. Finasteride is a 5α-reductase inhibitor that reduces the conversion of testosterone to dihydrotestosterone (DHT), a hormone that contributes to follicle miniaturization in male pattern hair loss. Topical finasteride is used in compounded products to target the scalp while potentially reducing systemic exposure compared with oral finasteride. It remains prescription-only and is generally intended for men due to risks in women of childbearing potential. Minoxidil is a vasodilator that prolongs the anagen (growth) phase of the hair cycle and increases follicle size, promoting hair regrowth when applied topically. It is one of the few FDA-approved treatments for hair loss. Tretinoin is a topical retinoid that may enhance scalp epidermal turnover and improve penetration of other actives, potentially increasing the effectiveness of minoxidil and finasteride in compounded formulations. This combination is not an FDA-approved commercial product but is prepared by compounding pharmacies under prescription. Use should be guided by a healthcare provider, and consistent application over months is typically required before visible results. Links for more information: Topical finasteride & minoxidil foam overview: https://www.keeps.com/our-products/topical-finasteride-minoxidil-foam/0 Safety info for finasteride/minoxidil/tretinoin compounds: https://support.careglp.com/support/solutions/articles/73000639209-finasteride-minioxidil-tretinoin-safety-information Compounded finasteride/minoxidil/tretinoin foam details: https://www.bayviewrx.com/formulas/Finasteride-2-5-Minoxidil-5-Tretinoin-0-025-Topical-Foam-Androgenetic-Alopecia-Alopecia-Areata-Female-Pattern-Hair-Loss-Telogen-Effluvium-Traction-Alopecia